(Press-News.org) A new 20-year study of nearly 11,000 adults in Bangladesh found that lowering arsenic levels in drinking water was associated with up to a 50 percent lower risk of death from heart disease, cancer and other chronic illnesses, compared with continued exposure.
Published today in the Journal of the American Medical Association, the study provides the first long-term, individual-level evidence that reducing arsenic exposure may lower mortality, even among people exposed to the toxic contaminant for years.
The landmark analysis, led by researchers at Columbia University and New York University, is important for public health because groundwater contamination from naturally occurring arsenic remains a serious issue worldwide. In the United States, more than 100 million people rely on potentially contaminated groundwater sources, especially private wells, for their drinking water. Arsenic is among the most common chemical pollutants.
“We show what happens when people who are chronically exposed to arsenic are no longer exposed,” said co-lead author Lex van Geen of the Lamont-Doherty Earth Observatory, which is part of the Columbia Climate School. “You’re not just preventing deaths from future exposure, but also from past exposure.”
The results provide the clearest evidence to date of the link between arsenic reduction and lower mortality, says co-lead author Fen Wu of NYU Grossman School of Medicine. For two decades, the research team followed each participant's health and repeatedly collected urine samples to track exposure, which they say strengthened the accuracy of their findings.
People whose urinary arsenic levels dropped from high to low had mortality rates identical to those who had consistently low exposure throughout the duration of the study. The larger the drop in arsenic levels, the greater the decrease in mortality risk. By contrast, individuals who continued drinking high-arsenic water saw no reduction in their risk of death from chronic disease.
Arsenic is a naturally occurring element that accumulates in groundwater, and because it has no taste or odor, people can unknowingly drink contaminated water for years. In Bangladesh, an estimated 50 million people have been exposed to drinking water with levels above the World Health Organization’s guideline of 10 micrograms per liter. The WHO has called it the largest mass poisoning in history.
Tracking exposure and mortality
From 2000 to 2022, the Health Effects of Arsenic Longitudinal Study (HEALS) tracked thousands of adults and tested more than 10,000 wells in Araihazar, Bangladesh, where many people rely on shallow tube wells with arsenic concentrations ranging from negligible to extremely high.
Researchers periodically measured arsenic levels in participants’ urine—a marker of ingested arsenic and a proxy for internal exposure—and recorded causes of death. These individual-level data allowed the scientists to compare health outcomes between those who reduced their exposure and those who remained highly exposed.
Throughout the project, national and community programs tested wells in Araihazar for arsenic and labeled them as safe or unsafe, prompting many households to switch to or install safer wells. Others continued using contaminated wells, creating a natural comparison group within the study.
Arsenic exposure dropped significantly in Araihazar over the study period. The average concentration in the wells people relied on fell by about 70 percent because many households switched to safer water sources. Urine tests confirmed the change: participants’ internal arsenic exposure declined by about 50 percent, on average, and remained lower through 2022.
These patterns held even after adjusting for differences in age, smoking, and socioeconomic status. Participants whose exposure remained high, or increased over time, continued to face significantly higher risks of death from chronic diseases.
Van Geen likened the impact of reducing arsenic exposure to quitting smoking: the health risks do not disappear immediately but decline steadily over time.
The findings highlight the importance of ensuring access to arsenic-free drinking water. In Bangladesh, measures such as testing well water, labeling unsafe water sources, drilling private wells and deeper government wells have already delivered measurable improvements for many people.
“Our findings can now help persuade policymakers in Bangladesh and other countries to take emergency action in arsenic ‘hot spots’,” says co-author Kazi Matin Ahmed of the University of Dhaka.
To expand access to safe water, the research team is working with the Bangladeshi government to make well data more accessible. They’re piloting NOLKUP (“tubewell” in Bangla), a free app developed from more than six million well tests. Users can search for specific wells, check arsenic levels and depths, and locate nearby safer sources. The app also helps planners identify communities most in need of new, deeper wells.
By showing that health risks decline even for those already exposed to arsenic, the study highlights a critical opportunity: investing in clean water can save lives within a generation.
“This finding is deeply rewarding. Public health is often the ultimate example of delayed gratification,” says Joseph Graziano, Professor Emeritus at Columbia University’s Mailman School of Public Health and a principal investigator of the decades-long research.
The study team comprised researchers from the New York University Grossman School of Medicine; Lamont-Doherty Earth Observatory and the Mailman School of Public Health at Columbia University; Boston University School of Public Health; Department of Geology, University of Dhaka; and the Institute for Population and Precision Health, University of Chicago.
The HEALS study was launched by Columbia University through the National Institute of Environmental Health Sciences’ Superfund Research Program, with most U.S. collaborators based at Columbia when the project began.
END
Reducing arsenic in drinking water cuts risk of death, even after years of chronic exposure
A 20-year study of 11,000 adults in Bangladesh found that reducing arsenic in drinking water cut deaths by up to 50 percent—even among people exposed to the toxic contaminant for years
2025-11-17
ELSE PRESS RELEASES FROM THIS DATE:
Lower arsenic in drinking water reduces death risk, even after years of chronic exposure
2025-11-17
A new 20-year study of nearly 11,000 adults in Bangladesh found that lowering arsenic levels in drinking water was associated with up to a 50 percent lower risk of death from heart disease, cancer and other chronic illnesses, compared with continued exposure. The study highlights the importance of ensuring access to arsenic-free drinking water and provides the first long-term, individual-level evidence that reducing arsenic exposure may lower mortality, even among people exposed to the toxic contaminant for years. The findings ...
Lowering arsenic levels in groundwater decreases death rates from chronic disease
2025-11-17
Reducing amounts of arsenic in drinking water can lower long-term deaths from cardiovascular disease and cancer, a new study shows.
Researchers at NYU Langone Health, Columbia University, and the University of Chicago say their landmark analysis is important for public health because groundwater contamination from naturally occurring arsenic remains a serious issue worldwide. In the United States, more than 100 million people rely on potentially contaminated groundwater sources, especially private wells, for their drinking water. Arsenic is among the most common chemical pollutants.
During the study, the drinking water and ...
Arsenic exposure reduction and chronic disease mortality
2025-11-17
About The Study: The findings of this study support an association between reduced arsenic exposure and improved health outcomes in populations exposed to contaminated drinking water.
Corresponding Authors: To contact the corresponding authors, email Yu Chen, PhD, (Yu.Chen@nyulangone.org) and Habibul Ahsan, MD, (hahsan@bsd.uchicago.edu).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.19161)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, ...
Parasitic matricide, ants chemically compel host workers to kill their own queen
2025-11-17
Fukuoka, Japan—In the ruthless world of parasitic ants, taking over a host colony is a matter of life and death. The conventional understanding has been that an invading queen must physically fight and kill the resident queen to seize control. However, a new study published in Current Biology details a more sinister strategy: a parasitic ant queen that chemically manipulates the host colony’s workers into executing their own mother.
“The initial discovery was made by my friend Taku Shimada, the first author of the paper, who has been passionate about ants since childhood and runs a popular blog called ‘AntRoom.’ He observed the colony infiltration ...
Clinical trials affected by research grant terminations at the National Institutes of Health
2025-11-17
About The Study: Approximately 1 in 30 trials and more than 74,000 trial participants were affected by grant funding disruptions. Affected trials disproportionately studied infectious diseases, prevention, and behavioral interventions, and were based in the Northeastern U.S. or in other countries. Because trials require sustained financial support to ensure operations and participant safety, unanticipated funding disruptions raise concerns about avoidable waste, data quality, and compromised ethical obligations to participants.
Corresponding Author: To contact the corresponding author, Anupam B. Jena, MD, PhD, email jena@hcp.med.harvard.edu.
To ...
Racial and ethnic disparities in cesarean birth trends in the United States
2025-11-17
About The Study: In this cohort study of births in the United States from 2012 to 2021, the rate of overall cesarean births decreased slightly over the study period. However, racial and ethnic disparities persisted, with increasing risk of primary cesarean births among non-Hispanic Black individuals compared with individuals from other racial and ethnic groups. Quality improvement efforts to reduce unnecessary cesarean births should address this inequity and the structural racism that drives it.
Corresponding Author: To contact the corresponding author, Marie J. Boller, MD, email boller@ohsu.edu.
To access the embargoed study: Visit our For The Media website ...
Light-intensity-dependent transformation of mesoscopic molecular assemblies
2025-11-17
Constructing out-of-equilibrium molecular assemblies that deviate from thermodynamic equilibrium is a central challenge in materials science. While numerous studies have reported the creation of such states using external energy sources such as chemical fuels or light, few systems can adaptively access different states depending on how much energy is input. Developing such systems could offer new design principles for advanced functional materials capable of flexibly adapting to environmental changes, much like biological systems.
In a recent study published online in Chem on November 17, 2025, researchers in Japan reported a supramolecular polymer system that can produce out-of-equilibrium ...
Tirzepatide may only temporarily suppress brain activity involved in “food noise”
2025-11-17
PHILADELPHIA—A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the brain’s “reward center” thought to be involved in food noise – but only temporarily.
Research suggests that the medication, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, originally developed to manage Type 2 diabetes, may be able to treat a wide range of conditions ...
Do all countries benefit from clinical trials? A new Yale study examines the data
2025-11-17
Do All Countries Benefit From Clinical Trials? A New Study Examines the Data
A new study led by Yale’s Jennifer Miller, PhD, found that medicines are not physically accessible in many of the countries where they are tested for FDA approval.
The findings were published in JAMA Internal Medicine.
For the study, researchers analyzed 172 FDA-approved medicines tested between 2015 and 2018 in nearly 90 countries. They found that five years after testing, only 24 percent of the medicines had received market authorization, or approval for distribution and patient access, in the countries where the clinical ...
Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma (version 2024)
2025-11-17
The therapeutic landscape for hepatocellular carcinoma (HCC) has been revolutionized by the advent of molecular targeted therapies and immune checkpoint inhibitors (ICIs). While these systemic treatments have significantly improved outcomes for patients with intermediate and advanced HCC, their use is accompanied by a spectrum of adverse events, with drug-induced liver injury (DILI) being a common and potentially serious complication. To address this growing clinical challenge, the Chinese Society of Hepatology convened a multidisciplinary panel of experts to formulate the "Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors ...
LAST 30 PRESS RELEASES:
Report on academic exchange (colloquium) with Mapua University
Sport in middle childhood can breed respect for authority in adolescence
From novel therapies to first-in-human trials, City of Hope advances blood cancer care at the American Society of Hematology (ASH) annual conference
Research aims to strengthen the security of in-person voting machines
New study exposes hidden Alzheimer’s 'hot spots' in rural Maryland and what they reveal about America’s growing healthcare divide
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers
IADR elects George Belibasakis as vice-president
Expanding the search for quantum-ready 2D materials
White paper on leadership opportunities for AI to increase employee value released by University of Phoenix College of Doctoral Studies
ASH 2025: New combination approach aims to make CAR T more durable in lymphoma
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukemia
How brain activity changes throughout the day
Australian scientists reveal new genetic risk for severe macular degeneration
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk
Precision immunotherapy to improve sepsis outcomes
Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence
Study finds most people trust doctors more than AI but see its potential for cancer diagnosis
School reopening during COVID-19 pandemic associated with improvement in children’s mental health
Research alert: Old molecules show promise for fighting resistant strains of COVID-19 virus
Journal of Nuclear Medicine Technology supplement highlights advances in theranostics and opportunities for growth
New paper rocks earthquake science with a clever computational trick
ASH 2025: Milder chemo works for rare, aggressive lymphoma
Olfaction written in bones: New insights into the evolution of the sense of smell in mammals
Engineering simulations rewrite the timeline of the evolution of hearing in mammals
New research links health impacts related to 'forever chemicals' to billions in economic losses
Unified EEG imaging improves mapping for epilepsy surgery
$80 million in donations propels UCI MIND toward world-class center focused on dementia
Illinois research uncovers harvest and nutrient strategies to boost bioenergy profits
How did Bronze Age plague spread? A sheep might solve the mystery
[Press-News.org] Reducing arsenic in drinking water cuts risk of death, even after years of chronic exposureA 20-year study of 11,000 adults in Bangladesh found that reducing arsenic in drinking water cut deaths by up to 50 percent—even among people exposed to the toxic contaminant for years